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PDZ domains are protein–protein interaction modules that recognize specific C-terminal sequences to assemble
protein complexes in multicellular organisms. By scanning billions of random peptides, we accurately map binding
specificity for approximately half of the over 330 PDZ domains in the human and Caenorhabditis elegans proteomes.
The domains recognize features of the last seven ligand positions, and we find 16 distinct specificity classes conserved
from worm to human, significantly extending the canonical two-class system based on position  2. Thus, most PDZ
domains are not promiscuous, but rather are fine-tuned for specific interactions. Specificity profiling of 91 point
mutants of a model PDZ domain reveals that the binding site is highly robust, as all mutants were able to recognize C-
terminal peptides. However, many mutations altered specificity for ligand positions both close and far from the
mutated position, suggesting that binding specificity can evolve rapidly under mutational pressure. Our specificity
map enables the prediction and prioritization of natural protein interactions, which can be used to guide PDZ domain
cell biology experiments. Using this approach, we predicted and validated several viral ligands for the PDZ domains of
the SCRIB polarity protein. These findings indicate that many viruses produce PDZ ligands that disrupt host protein
complexes for their own benefit, and that highly pathogenic strains target PDZ domains involved in cell polarity and
growth.
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Introduction
Modular protein–protein recognition domains are in-
volved in the assembly of numerous intracellular complexes
that mediate diverse cellular functions. Thousands of
recognition domains are contained within the human
proteome, and these have been classiﬁed into over 70 distinct
families [1]. The PDZ (PSD-95/Discs-large/ZO-1) domain
family is particularly interesting because it plays a key role
in the development of multicellular organisms, in which PDZ
domains are often found as components of multidomain
scaffolding proteins involved in cell polarity and intercellular
interactions [2,3]. PDZ domains are often embedded in
proteins that assemble specialized subcellular sites, such as
epithelial junctions [4], neuronal postsynaptic densities [5],
and immunological synapses of T cells [6]. The biological
importance of PDZ domains is further underscored by the
identiﬁcation of various PDZ-containing proteins as human
disease and pathogen effector targets [4,7–15].
Although the human genome encodes over 250 PDZ
domains in over 100 proteins, most studies to date have
focused on individual family members or a handful of
domains [16–20]. Nevertheless, these studies uncovered
general features of PDZ domain structure and function. Aside
from unusual cases in which phospholipids [21,22] or internal
motifs [23,24] are recognized, PDZ domains assemble intra-
cellular complexes principally by recognition of C-terminal
sequences in which speciﬁcity is mediated by interactions
between ligand side chains and the PDZ domain binding
surface [2]. Early studies grouped PDZ domains into two main
speciﬁcity classes based on two ligand positions: class 1 (X[T/
S]X/COOH) and class 2 (X/X/COOH), where X is any residue
and / is a hydrophobe [16,25]. Less common classes of PDZ
domains, such as class 3 recognizing the motif X[ED]X/COOH,
were also identiﬁed [17]. However, subsequent studies have
shown that the PDZ binding cleft can interact speciﬁcally with
up to seven C-terminal ligand residues, enabling differ-
entiation between biologically diverse ligands [20]. A recent
large-scale analysis of mouse PDZ domains conﬁrmed the
highly speciﬁc nature of PDZ–ligand interactions but did not
address the issue of PDZ domain classiﬁcation [26]. To better
understand how PDZ domains mediate cellular function and
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PLoS BIOLOGYhow hundreds of family members may compete for hundreds
of potential ligands, we conducted a large-scale analysis using
phage-displayed random peptide libraries. This establishes a
speciﬁcity map and comprehensive classiﬁcation system for
the PDZ domain family, which provides insight into domain
function and evolution and can be used to make novel
discoveries about PDZ domain signaling systems.
Results
PDZ Domain Specificity Potential
We used C-terminal peptide-phage display [27,28] to
conduct a large-scale analysis of PDZ domain speciﬁcity,
focusing on human and, for comparison, the simple metazoan
Caenorhabditis elegans. Previous studies have shown that a
phage-displayed combinatorial peptide library approach is a
powerful tool to elucidate PDZ domain speciﬁcity and may be
used to identify biologically relevant targets [20,29,30]. We
cloned 72 out of 82 worm and 96 out of 254 human PDZ
domains detected by three domain detection tools, BLAST
[31], PFAM [32], and SMART [33]. The domain boundaries
were deﬁned as the union of all predicted domain regions
plus ten amino acids on each side.
The 168 cloned domains were expressed as GST fusion
proteins, and 145 of these (57 worm and 88 human) could be
puriﬁed in a stable, soluble form. These 145 proteins were
used in binding selections with a C-terminal phage-displayed
library containing greater than 10 billion random peptides,
and we were successful in obtaining binding peptides against
82 domains (28 worm and 54 human). Failure to ﬁnd binding
peptides for the remaining domains may be due to instability
of isolated domains or a requirement for larger, structured
ligands not represented in our random peptide library [2].
Nonetheless, by sequencing approximately 10,000 binding
clones, we were able to isolate approximately 3,100 unique
peptide ligands for 82 PDZ domains (Tables S1 and S2). The
domains used in this analysis and all associated peptides are
available in a computer-readable format at http://baderlab.
org/Data/PDZ.
Consistent with the canonical preference of PDZ domains
for hydrophobic C termini, the vast majority of the selected
sequences (.97%) terminate with a hydrophobic residue, and
for each domain, we therefore aligned the sequences on the
basis of the C-terminal anchor position. The small number of
peptides that are not canonical C-terminal binders were not
considered in our analysis, although they are made available
in our peptide ﬁles for others to analyze. To statistically
model the binding speciﬁcity of each PDZ domain to enable
computational analysis, each aligned peptide ligand set was
used to create a position weight matrix (PWM). Each matrix
column captures the amino acid binding preference of a PDZ
domain at a ligand position as a probability distribution.
From this PWM, the speciﬁcity of each ligand position is
visualized as a sequence logo [34] and summarized using a
speciﬁcity potential (SP) score ranging from least speciﬁc (any
amino acid is recognized, SP score ¼ zero) to most speciﬁc
(only a single amino acid is recognized, SP score ¼ one)
(Figure 1A). For 72 PDZ domains, we had sufﬁcient peptide
data (n . 10) to calculate reliable SP scores. Our analysis
reveals that essentially all PDZ domains recognize the last
three ligand positions (0,  1, and  2), the majority recognize
positions 3 and 4, and some recognize positions 5 and 6
(Figure 1B, SP . 0.2; Figure 1C, mean SP). The total speciﬁcity
score per domain (SP
t), calculated by summing the SP scores
across the last nine ligand positions (Figure 1D), shows that
most PDZ domain binding sites achieve high speciﬁcity
through recognition of multiple features of the last seven
residues of C-terminal peptide ligands (Table S3). These
patterns are conserved across worm and human. Further-
more, there is no signiﬁcant difference between the SP
t
values for worm (mean ¼ 3.2 6 0.9) and human domains
(mean ¼ 3.1 6 1.0), indicating that increased human genome
complexity has not been accompanied by a corresponding
increase in overall PDZ domain speciﬁcity.
We created a speciﬁcity map organizing all 82 successfully
mapped PDZ domains. Hierarchical clustering was used to
automatically place similar PDZ binding proﬁles (described
by PWMs) in close proximity (Figure 2). This map reveals that
approximately 90% of the domains ﬁt into 16 distinct
speciﬁcity classes, and the remainder represent unique
speciﬁcities. By considering all recognized ligand positions,
our comprehensive speciﬁcity map signiﬁcantly expands the
canonical PDZ domain classiﬁcation system, which assigned
only two main classes on the basis of speciﬁcity for ligand
position  2 [16].
PDZ Domains Are Versatile and Robust
Considering each ligand position independently, there are
a striking number of distinct speciﬁcities for the last six
positions (Figure 3). For instance, all domains prefer hydro-
phobic C termini, but there are eight distinct speciﬁcities for
position 0. This suggests a vast potential for the PDZ domain
family to bind different sequences. To assess the contribu-
tions of domain binding site positions to ligand binding and
the speciﬁcity capacity of the PDZ domain family, we mutated
t e nE r b i nP D Zd o m a i n( E R B B 2 I P - 1 )c o r eb i n d i n g - s i t e
positions and determined speciﬁcity proﬁles for each of the
91 single-residue mutants. The core binding positions are
those that make contact (closer than 4.5 A ˚ ) with the peptide
ligand in all of nine different PDZ domain structures (Protein
Data Bank [PDB] entries 1N7T, 2H2B, 2H2C, 1I92, 2HE2,
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Author Summary
The PDZ domain is a structural domain that functions as a protein–
protein interaction module that recognizes specific C-terminal
peptide sequences to assemble intracellular complexes important
in signaling pathways of multicellular organisms. These modules are
associated with human disease and are targets of viruses and other
pathogens. By examining peptide specificity and substrate diversity
of roughly one half of the PDZ domains known to exist in human
and the nematode Caenorhabditis elegans, we were able to show
that PDZ domains are more specific than previously appreciated.
PDZ domains also remain functional under high mutational
pressure, and only a few of the vast number of possible PDZ
domain specificities are utilized in nature. These PDZ domain
specificities are conserved from human to worm, implying that the
specificities evolved early and were reused over evolution instead of
being reshaped. The specificity map generated here was used to
predict and experimentally confirm new viral PDZ-binding motifs.
We present evidence that pathogenic viruses, including avian
influenza, bind host PDZ domains via these motifs, thereby
competing with signaling by host complexes, which leads to
disruption of growth and polarity of the host cells.Figure 1. PDZ Domains Are Highly Specific across Multiple Ligand Positions
A total of 72 PDZ domains (each with greater than ten peptides) corresponding to 2,998 ligands were analyzed to assess specificity for each ligand
position. Specificity was measured using the SP score, which ranges from zero (least specific) at a given ligand position to one (most specific). Bars are
colored as follows: all PDZ domains (black), human (grey), or worm (white).
(A) Specificity profile for a representative PDZ domain (C34F11.9a-1) with SP scores shown above each ligand position.
(B) Fraction of PDZ domains exhibiting significant specificity (SP . 0.2) at each ligand position.
(C) The mean SP value at each ligand position.
(D) The distribution of total SP (SP
t) summed over all ligand positions.
doi:10.1371/journal.pbio.0060239.g001
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The PDZ Domain Family Specificity MapFigure 2. Specificity Map Classifies the PDZ Domain Family
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The PDZ Domain Family Specificity Map1BE9, 2GZV, 1IHJ, and 1N7F). At each of the ten positions,
mutations were made to amino acids that are abundant in the
82 natural human and worm PDZ domains for which we
collected phage-derived speciﬁcity proﬁles (Figure 2).
To minimize potential destabilization caused by structur-
ally deleterious mutations, selections were performed at 4 8C,
and under these low stringency conditions, the wild-type
speciﬁcity proﬁle (Figure 4) was somewhat less speciﬁc than
that at room temperature (wild-type ERBB2IP-1 logo in
Figure 2, class 1h). Phage selections were successful in all
cases, and a total of approximately 3,400 unique ligands were
sequenced. We compared the speciﬁcity proﬁle of each
mutant (Figure S1) to that of the wild type and visualized
the differences as a heat map (Figure 4).
Positions 0 and  2 deﬁne the most commonly used PDZ
classiﬁcation system [16]. The only signiﬁcant change in
speciﬁcity for position 0 was due to a substitution at position
b1:b2–7, which lines the hydrophobic pocket that accepts the
C-terminal ligand side chain. Changes in speciﬁcity for
position  2 were caused by mutations in the a2 helix
positions a2–1 and a2–5, which are close to the ligand side
chain at this position [35]. The four substitutions at position
a2–1 that do not alter speciﬁcity signiﬁcantly (Y, N, Q, and K)
are all capable of forming hydrogen bonds, and thus, can
substitute functionally for the wild-type H, which hydrogen
bonds with T at position  2 of an optimal ligand for
ERBB2IP-1 [36]. The remaining 14 mutations result in class
2 speciﬁcity proﬁles with preference for hydrophobes at
All 82 PDZ domains studied were clustered to create a specificity map, which was used as a guide to manually define PDZ specificity classes. Of the 82
domains, 73 are assigned to one of 16 classes, labeled to the right of each domain name. For consistency with the established PDZ domain classification
system [16], each class is denoted by a numeral based on the specificity for position 2, followed by a letter to account for specificity across the rest of
the binding site. C. elegans domains are highlighted in yellow. Sets marked with identical Roman numerals in parentheses are homologous PDZ
domains in human/worm orthologs. Domains that exhibit unique specificities not part of any class are denoted by asterisks (*). The 16 classes are
defined by the following C-terminal motifs: 1a (/[K/R]XSDV); 1b (X[R/K]ET[S/T/R/K]/); 1c (//ETXL); 1d (ETXV); 1e (TWW); 1f (XXTWW); 1g (///[T/S][T/
S]XW); 1h (//[D/E][T/S]WW); 2a (FDXXC); 2b (WXXFDV); 2c (WX/DW); 2d (//X[E/D]///); 2e (////); 2f ([D/E]/X/); 3a (WX[S/T]DWW); 4a (X/GWF);
/, hydrophobic (V, I, L, F, W, Y, M); X, aromatic (F, W, and Y); W, aliphatic (V, I, L, and M); and X, nonspecific.
doi:10.1371/journal.pbio.0060239.g002
Figure 3. Distinct Specificities of PDZ Domain Binding Sites
The specificity profiles of 72 PDZ domains reveal eight, seven, eight, seven, five, and three distinct specificities for ligand positions 0, 1, 2, 3, 4, and
 5, respectively. At each position, distinct specificities are shown (magenta) with either the single-letter amino acid code or symbols, as follows: þ,
positive charge;  , negative charge; /, hydrophobic (V, I, L, F, W, Y, and M); W, aliphatic (V, I, L, and M); and X, aromatic (F, W, and Y).
doi:10.1371/journal.pbio.0060239.g003
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The PDZ Domain Family Specificity Mapposition  2. These results indicate that speciﬁcity for ligand
positions  2 and 0 depends mainly on direct amino acid
residue side chain interactions.
Wild-type ERBB2IP-1 prefers W at ligand position  1, and
although no mutation completely alters this preference, six
mutations expand speciﬁcity to include other residue types.
These mutations occur at four positions spread throughout
the PDZ domain, and only the effects at one position (b3:a1–
1) can be explained by changes in direct residue contacts.
Mutations at two positions located far from position 1( a2–1
and b2–4) expand speciﬁcity to include D, and it is likely that
these mutations alter the ligand orientation and allow a D
side chain to interact with the R side chain at position b3–5,
which sits between ligand positions  1 and  3 [36]. The
inﬂuence of indirect effects is demonstrated dramatically by
the introduction of a ﬂexible G residue at b3–4, which
produces a PDZ domain with two distinct speciﬁcity proﬁles,
one wild type and the other completely altered at positions
 1 and  3. Thus, speciﬁcity for ligand position  1 can be
inﬂuenced by direct and indirect interactions at positions
throughout the PDZ binding site.
Mutations at seven PDZ positions affect speciﬁcity for
position 3, but only three of these positions (b2–2, b3–4, and
b3–5) are in direct contact with this ligand position.
Interestingly, many mutations at four other positions
(b1:b2–7, b3:a1–1, a2–1, and a2–5) accentuate, rather than
alter, the wild-type preference for negatively charged
residues at position  3. A similar situation appears to exist
for the upstream 4 and 5 positions, as the slight preference
of the wild-type domain for hydrophobic residues at these
positions (Figure 2, class 1h) is accentuated by mutations at
ﬁve positions (b1:b2–7, b2–2, b2–4, b3–5, and a2–5), and most
of these effects cannot be explained by changes in direct
contacts. These effects may be caused by ligand orientation
changes, which may allow for more favorable interactions
between the PDZ domain and ligand residues upstream of
position  2. Additionally, some mutations may weaken the
energetic contributions from interactions with the three C-
terminal ligand positions, and thus, ligand binding may
become more dependent on favorable interactions involving
upstream ligand positions. Thus, weaker interactions with
Figure 4. Sequence Determinants of PDZ Domain Specificity
Heat map summary of the effects of mutations on the specificity of
ERBB2IP-1. Each row represents one mutant, ordered by PDZ domain
binding-site position (labeled to the right of each set of rows), and each
column represents one ligand position. Mutations were chosen to
represent the diversity of amino acids in 82 natural PDZ domains for
which we have phage data. To minimize potential destabilization caused
by structurally deleterious mutations, selections were performed at 4 8C,
and under these low stringency conditions, the wild-type specificity
profile, shown at top left, was somewhat less specific than that at room
temperature (Figure 2). The mutation listed to the left of each row, at the
PDZ domain position listed at the right according to a structure-based
nomenclature [55], causes a change in specificity, shown in each row.
The blue-to-red gradient indicates increasing difference relative to wild
type, normalized per column with significant differences highlighted in
green (greater than one standard deviation away from the mean
difference over the column). Selected mutant profiles are highlighted
(depicted as sequence logos to the left of the corresponding row), with
significant specificity changes in the logo boxed in red. Structures of
ERBB2IP-1 with a bound peptide ligand [36] are shown with mutated
positions depicted as spheres. Red side chains indicate ligand positions
for which specificity is altered by mutations at PDZ positions shown as
red spheres.
doi:10.1371/journal.pbio.0060239.g004
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The PDZ Domain Family Specificity Mapligand residues at positions  3,  4, and  5 can be affected in
multiple indirect ways by mutations at numerous positions in
the binding site.
Our mutational and speciﬁcity prediction analyses provide
general insights into PDZ domain speciﬁcity and have
implications for prediction of binding speciﬁcity from
domain sequence. Because speciﬁcity for ligand position  2
is mediated by local contacts with the PDZ a2 helix, point
mutations at a2–1 and a2–5 are sufﬁcient to substantially
alter this speciﬁcity. Furthermore, there is a strong correla-
tion between speciﬁcity for ligand position  2 and the
sequence at the a2–1 position, as 44 of our 82 mapped
domains (Figure 2) contain an H at the a2–1 position, and 37
(84%) of these prefer ligands containing T/S at position  2.
We were not able to detect other strong correlations between
individual PDZ domain positions and ligand speciﬁcity. In
contrast, speciﬁcity for  1,  3, and positions further up-
stream depends on positions scattered throughout the PDZ
domain and likely involves indirect conformational effects
that subtly alter speciﬁcity at these positions without
changing the speciﬁcity class. Thus, speciﬁcity in a PDZ
domain is determined by multiple structural and chemical
mechanisms involving both direct contacts and cooperative,
long-range effects (Figure 5). Consequently, the binding site
must be considered as a whole to accurately predict
speciﬁcity from primary sequence.
The clear selection of ligands by all PDZ mutants shows
that the domain can function under high mutational
pressure. Furthermore, 35 of 91 mutations analyzed caused
a signiﬁcant change in speciﬁcity for at least one ligand
position (Figure 4). Taken together, these results show that
PDZ domains are versatile and robust, as mutations
frequently cause a change, rather than a loss of function.
Conserved Specificity and Domain Expansion
Because expansion of PDZ and other modular domains is
correlated with increased organism complexity [37], we asked
what role PDZ versatility plays in the evolution of complexity.
Almost all PDZ speciﬁcity classes we deﬁne contain human
and worm representatives, indicating that most of the human
speciﬁcities are also present in the worm. Our dataset
contains six worm/human ortholog gene pairs with mapped
PDZ domain binding speciﬁcity in both species (Figure 6).
Four of these pairs have nearly identical speciﬁcity proﬁles,
and two are very similar. This level of conservation across
more than one billion years of evolution separating worm
from human [38] suggests that these speciﬁcity proﬁles are
important for biological function. The limited number of
Figure 5. Mutations Affecting PDZ Domain Specificity
ERBB2IP-1 (grey) is shown with a bound peptide ligand (WETWVCOOH; cyan) (PDB entry 1N7T) [36]. PDZ domain binding-site positions that were
subjected to mutagenesis are shown as spheres. In each panel, PDZ domain positions at which mutations affected specificity for the indicated ligand
position are colored red and other mutagenized positions are colored green. PDZ domain positions are labeled in black according to a structure-based
nomenclature [55].
doi:10.1371/journal.pbio.0060239.g005
PLoS Biology | www.plosbiology.org September 2008 | Volume 6 | Issue 9 | e239 2049
The PDZ Domain Family Specificity MapFigure 6. Specificity Profiles of Orthologous Domains Are Highly Conserved
AllwormandhumanorthologpairswithmappedPDZdomainsinourdatasetareshown.Thedomainarchitecture,as definedbySMART[33],isshownfor
eachworm(top) andhuman(bottom)proteinin anorthologpair.The specificity profilesdefinedby peptidephagedisplay areshownbelowor abovethe
worm or human PDZ domains, respectively. The name and length of each protein is indicated on the left or right, respectively. The orthologous protein
pairs are drawn to scale. The following protein pairs could be unambiguously identified as orthologs on the basis of common domain architecture and
high sequence identity: (A) C34F11.9a/DVL2, (B) F54E7.3/PARD3, (C) Y54G11A.10/LIN7A, (D) C25F6.2a/DLG1, (E) W03F11.6/MLLT4, and (F) F17E5.1a/CASK.
doi:10.1371/journal.pbio.0060239.g006
PLoS Biology | www.plosbiology.org September 2008 | Volume 6 | Issue 9 | e239 2050
The PDZ Domain Family Specificity MapFigure 7. PDZ Domain Sequence Identity Accurately Predicts Binding Specificity
(A) ERBB2IP-1 structure (grey) is shown with a bound peptide ligand (WETWVCOOH; colored) [36]. PDZ domain binding site positions are shown as
spheres, and positions that were analyzed by mutagenesis are colored green. PDZ positions are labeled in black according to a structure-based
nomenclature [55], and peptide positions are labeled in red. We defined the PDZ binding site as 17 residues that make contact with the ligand (closer
than 4.5 A ˚) in at least one of nine different structures (PDB entries 1N7T, 2H2B, 2H2C, 1I92, 2HE2, 1BE9, 2GZV, 1IHJ, and 1N7F).
(B) The relationship between binding-site sequence identity and specificity profile similarity. Each point represents a pair of PDZ domains from our
mapped set. Red circles represent pairs assigned to the same class, as defined in our specificity map, and blue squares represent all other pairs. The
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The PDZ Domain Family Specificity Mapconserved speciﬁcity classes used across two distant species
suggests that most PDZ domain speciﬁcity classes arose early
in evolution, and evolutionary constraints prevented new
classes from forming following the divergence of worm and
human. Consequently, additional complexity in the human
PDZ domain family compared to that of the worm apparently
arose through domain expansion and shufﬂing, rather than
from the evolution of radical new speciﬁcities.
Specificity Predicted from Primary Sequence
Given the limited number of natural speciﬁcity classes and
the mutant Erbin PDZ domain–ligand correlations observed,
we asked whether we could use primary sequence to classify
binding speciﬁcity of wild-type PDZ domains. Our extensive
dataset based on phage-displayed random peptide libraries
shows a clear correlation between binding-site identity and
speciﬁcity. Domain pairs with binding-site sequence identi-
ties greater than 70% have speciﬁcity proﬁles with equivalent
similarity to those within a speciﬁcity map class (Figure 7).
This is the ﬁrst time such a correlation has been shown for
PDZ domains. We ﬁnd that 69 of the remaining 254
unmapped worm and human PDZ domains have greater than
70% binding-site identity to mapped domains, and thus are
predicted to have near identical binding proﬁles (Figure 8
and Table S4). An analogous analysis using full-length PDZ
domain sequences reveals that domains with greater than
50% overall identity also exhibit highly similar speciﬁcity
proﬁles (Figure S2). Thus, by combining experimentally
mapped and predicted PDZ domain binding speciﬁcities, we
roughly double the size of our PDZ domain speciﬁcity map
and achieve 45% coverage of 336 predicted worm and human
PDZ domains. As these novel rules require only in silico
analysis of primary sequence and perform well across worm
and human, it should be possible to predict the speciﬁcity of a
given PDZ domain sequence in any organism.
Endogenous PDZ Interactions
One major application of our PDZ domain speciﬁcity map
is protein interaction prediction. As previously observed for
numerous PDZ domains, phage display selects high-afﬁnity
peptide ligands through an iterative panning process, some of
which are physiologically relevant [20,29,30,39,40]. These
studies have also demonstrated a strong correlation between
phage-derived PWM scores and afﬁnities determined for
synthetic peptides. However, the in vivo ligand interactions
for any given PDZ domain depend on its intrinsic peptide
speciﬁcity, the concentration and context of the protein in
which it is located, and the range and concentration of
accessible ligands. Also, some ligands may interact with
suboptimal afﬁnities to regulate speciﬁc biological processes.
Thus, endogenous C termini closely matching our mapped
speciﬁcities are likely to bind the given PDZ domain in vitro,
but determination of in vivo binding requires additional
experimental support.
To signiﬁcantly reduce the human PDZ interactome search
space and prioritize interactions for future experimental
testing, we detected the best matched C-terminal sequences
in the human proteome for individual domains using a PWM-
based scoring algorithm and a score threshold that strin-
gently allows only the top few hits (Table S5). The network of
potential human PDZ domain mediated protein interactions
obtained in this manner contains 322 interactions between
our 54 experimentally mapped PDZ domains and 228 human
proteins. These high-scoring ligands are signiﬁcantly en-
riched in known PDZ interactors (27 interactions are known,
p ¼ 8.6 3 10
 18) (Table S5) and in gene function annotation
consistent with known PDZ ligand-associated functions
(Figure S3) [2–4]. Thus, our prioritized list is likely enriched
in novel bona ﬁde human PDZ protein interactions.
Our prioritization approach is useful because potential
ligands can be considered for experimental follow-up in
order of similarity to the phage-mapped speciﬁcity proﬁle.
For instance, when studying a particular protein of interest, it
may be useful to expand the list of potential ligands to
include additional lower-scoring ligands that may nonetheless
be physiologically relevant. To illustrate the utility of this
approach, we focused on DLG1, one of the ﬁrst and best
characterized PDZ-containing proteins (Table S6) [2,5,41],
and extended the potential ligand list for the three DLG1
PDZ domains by choosing a less stringent score threshold.
Our predicted interactions capture eight of the 11 known
ligands for DLG1 (Table S7) and identify many additional
potential ligands with scores comparable to those of the
known ligands. The list includes many known ligands for the
closely related DLG homologs (DLG2,  3, and  4) (Table S6),
and is enriched in gene function annotations consistent with
known functions of the DLG homologs (Figure S4), which are
involved in establishing and maintaining cell polarity, and
interact with ion channels, guanyl-nucleotide exchange
factors, and other signal transduction proteins [2,5,41].
Pathogenic PDZ Interactions
Pathogenic viruses and bacteria use short linear peptide
motifs that target PDZ domains and other peptide-binding
modules to perturb host signaling networks [8,10–13]. To
study the extent of this pathogenic subversion of host cellular
processes, we computationally identiﬁed 89 viral proteins
with C termini matching mapped PDZ domain speciﬁcities
better than the potential endogenous interactors deﬁned
above. These cover all PDZ domain speciﬁcity classes (Table
S5). Our results suggest that many viruses speciﬁcally target
distinct PDZ domain classes with high-afﬁnity ligands that
compete with endogenous interactors and interfere with
normal physiology.
To further explore viral targeting of PDZ domain proteins,
we focused on SCRIB, a protein known to be targeted by
human papilloma virus (HPV) [10]. SCRIB contains multiple
PDZ domains and is involved in establishing and maintaining
membrane polarity in epithelia, neurons, and T cells [4–6,40].
We identiﬁed numerous potential SCRIB viral ligands in our
initial network and in an additional network derived from a
recent database of avian inﬂuenza genomes [13]. We used a
less stringent score cutoff because we desired a more focused
and sensitive search designed to be experimentally validated.
We measured in vitro afﬁnities of ten potential SCRIB viral
ligands using synthesized peptides (peptides 1–10, Figure 9A).
lower-right quadrant, absent of data points, contains an example for one pair of PDZ domains (ERBB2IP-1 and LRRC7–1), which exhibit a specificity
profile similarity of 0.95 and a binding-site sequence identity of 0.88 (sequence mismatches are shown in red).
doi:10.1371/journal.pbio.0060239.g007
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The PDZ Domain Family Specificity MapFigure 8. Prediction of PDZ Domain Specificity
A network view of predicted PDZ domain specificities. Worm and human PDZ domains are shown as blue or pink nodes, respectively. Diamonds denote
domains with experimentally phage-mapped specificity profiles, and circles denote domains with predicted specificity profiles. Lines connect domains
with greater than 70% sequence identity in the binding site, and line width is proportional to sequence identity. Connected domains are predicted to
have high specificity profile similarity scores (.0.83). Network was created using Cytoscape 2.5 [54].
doi:10.1371/journal.pbio.0060239.g008
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The PDZ Domain Family Specificity MapFigure 9. Viral Proteins Interfere with Host Cellular Function by Targeting the PDZ Domains of SCRIB
(A) Many viral proteins bind SCRIB PDZ domains. Affinities were determined as IC50 values for peptides representing viral C termini binding to SCRIB
PDZ domains and the first PDZ domain of ZO-1 (TJP1–1) [20]. Ligand sequence positions that match the specificity profiles for SCRIB, TJP1–1, or both,
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The PDZ Domain Family Specificity MapEach peptide interacts with at least one SCRIB PDZ domain,
but not, in general, with the ﬁrst PDZ domain of ZO-1 (TJP1–
1), which has an overlapping, but different, speciﬁcity [20]. As
a further test, we found that a Herpes virus ligand (peptide
12) matching the speciﬁcity proﬁles of SCRIB and ZO-1 PDZ
domains bound to both, while another ligand (peptide 13)
matching only the ZO-1 PDZ domain speciﬁcity proﬁle
interacted only with this domain. These experiments show
that our speciﬁcity map is useful to guide experiments and
that viral proteins contain C-terminal motifs that are capable
of speciﬁcally targeting distinct sets of PDZ domains.
Some of our predicted viral ligands are known, whereas
many are novel. The HPV E6 protein (peptide 1) is known to
disrupt SCRIB function and causes loss of epithelial cell
polarization and concomitant hyperproliferation [10], and
the PDZ-binding motif is only present in high-risk, oncogenic
HPV strains. PDZ-binding motifs are also present in the Tax
proteins of human T-lymphotrophic (HTLV) type 1 viruses
(HTLV-1) (peptide 2) that cause adult T-cell leukemia/
lymphoma (ATLL), but are absent from HTLV type 2 viruses
that do not cause lymphoproliferative disorders [12]. The
HTLV-1 Tax protein has been shown to interact with other
PDZ domains [12], but we now show previously unreported
interactions with SCRIB. In another example, the NS1
proteins of inﬂuenza A from avian and highly pathogenic
human strains typically contain negatively charged residues
at position  3 and can interact with many PDZ domains,
whereas those from less pathogenic human strains typically
contain positively charged residues at this position and show
low reactivity with PDZ domains [13]. This is consistent with
our speciﬁcity map (Figure 2) and with our binding data
showing that the C termini of NS1 proteins from two avian
inﬂuenza strains (peptides 9 and 10) interact with the SCRIB
PDZ domains, but one from a low-pathogenicity human
strain (peptide 11) does not. These conﬁrmations, and new
viral–SCRIB interactions we ﬁnd involving herpes, vaccinia,
myxoma, and ﬁbroma viruses (peptides 3–8), suggest that
many pathogenic viruses utilize a common mechanism to
advantageously target SCRIB-mediated complexes involved
in cell polarity and growth control.
To further explore this hypothesis, we investigated whether
the PDZ-binding motif alone is sufﬁcient to induce effects
associated with pathogenic viral infections. Based on our PDZ
speciﬁcity map, we designed a synthetic peptide that binds to
the SCRIB PDZ domains with high afﬁnity (peptide 14). We
recently described an interaction between the C terminus
(ESIVCOOH) of the cell-surface receptor Crtam and SCRIB in
T cells, which is critical to attenuate proliferation and
maintain a late phase of T cell polarity [40]. Our designed
SCRIB PDZ-binding peptide abrogates these functions and
causes loss of late-phase T cell polarization and reverses the
hypoproliferative effects of Crtam. In contrast, a nonbinding
control peptide (peptide 15) has no effect (Figure 9). These
effects are remarkably similar to the hyperproliferative
phenotypes previously observed to be induced by the Tax
protein of HTLV-1 in lymphocytes [12] and the E6 protein of
high-risk HPV in epithelial cells [10]. The induction of
hyperproliferation is likely to be advantageous for viral
replication in general, and thus, it appears that the ability to
disrupt polarity by interference with SCRIB PDZ domain
complexes is a crucial factor in conferring high pathogenicity
to many viruses, including HPV, HTLV, and inﬂuenza A.
Discussion
We have presented the ﬁrst large-scale speciﬁcity map of a
domain family across species, based on approximately 3,100
peptide ligands, covering approximately one half of the
combined set of 336 predicted PDZ domains encoded by the
human and C. elegans genomes. We ﬁnd that the PDZ domain
family is surprisingly complex and diverse, recognizing up to
seven C-terminal ligand residues and forming at least 16
unique speciﬁcity classes across human and worm. Further
interpretation of our map reveals that PDZ domains are
versatile, capable of binding diverse ligand sequence motifs,
and are robust under high mutational load. Highly mutagen-
ized WW and SH3 domain sequences also retain the ability to
recognize proline-rich sequences [42,43], suggesting that
functional robustness under high mutational pressure may
be a general feature of peptide-binding modules. Although
we ﬁnd that the PDZ domain family likely evolved by domain
expansion rather than from evolution of radically new
speciﬁcities, the robustness of the PDZ domain may be ideal
for supporting rapid evolution of interaction networks
through testing of many functional variants under evolu-
tionary pressures that select for novel ligands.
For the ﬁrst time to our knowledge, we ﬁnd a predictive
correlation between PDZ domain sequence and binding
speciﬁcity. This correlation bridges a gap in our ability to
predict protein interactions and signaling networks from a
genome. Because the correlation holds across worm and
human, it can likely be used for accurate in silico predictions
of PDZ domain speciﬁcity in other species. The predictive
correlation will likely improve by considering additional
features of the domain and ligand, including additional
physicochemical and structural properties, class-speciﬁc
binding sites, and cooperative and indirect effects of residues
across the entire domain [44].
One major application of the PDZ domain speciﬁcity map
is the prediction of interaction networks that provide insights
are colored green, blue, or red, respectively. Orange and yellow indicate high-affinity (IC50 , 10 lM) or moderate-affinity (IC50 . 10 lM) interactions,
respectively. Asterisks (*) indicate no detectable interaction (IC50 . 500 lM). Double asterisks (**) indicate influenza A strain designations [13], rather
than RefSeq accession numbers.
(B) Loss of the late phase of T cell polarization induced by our designed synthetic peptide that targets SCRIB PDZ domains 1, 2, and 3. The receptor
Crtam interacts with the PDZ domains of SCRIB to control cell growth and maintain polarity of T cells [40]. These effects are reversed by the addition of
our designed peptide (P-RSWFETWV, peptide 14) that binds with high affinity to the SCRIB PDZ domains, but not by a designed nonbinding peptide
with mutations at the 0 and  2 positions (P–RSWFEAWA, peptide 15). The symbol P denotes the internalization sequence from the Antennapedia
protein (RQIKIWFQNRRMKWKK), which has been shown to be internalized into cells [56]. Naive Crtam
 /  CD4 T cells were electroporated with plasmid
DNA expressing Crtam or a mock DNA control. Cells were treated with synthetic peptides (1.0 lM) and stained for Talin, a marker for the leading edge of
polarized T cells [40].
(C) Our designed SCRIB PDZ-binding peptide (peptide 14) triggers T cell proliferation. Cells were treated with plasmid DNA and peptides, as describedi n
(B), and cellular proliferation was measured by the incorporation of [
3H]-thymidine. Data are representative of three independent experiments. Error
bars indicate the standard deviation (SD). The p-value was determined by statistical analysis performed with a control using the Dunnett method.
doi:10.1371/journal.pbio.0060239.g009
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The PDZ Domain Family Specificity Mapinto functions of PDZ domains in the cell. We have described
a preliminary use of this map to prioritize human PDZ-
mediated protein interactions, which directly led to novel
insights into normal [40] and pathogen biology. Ideally,
computational predictions would be more robust and less
dependent on experimental support. A major impediment to
domain-based protein interaction prediction is assessing
predicted interaction validity, due to a dearth of bona ﬁde
PDZ ligands in the literature. This is further complicated
because many interactions are known only for full-length
proteins, often containing multiple PDZ domains. Thus, there
are not enough known domain–peptide interactions to
robustly learn optimal prediction parameters and accurately
measure sensitivity and speciﬁcity. For instance, there is only
one known worm interaction for our mapped PDZ domains,
involving the lin-7 PDZ-containing protein that interacts with
the C terminus of let-23 (the worm homolog of the epidermal
growth factor receptor) [45], but this single interaction does
agree with our data. Notwithstanding this limitation, higher-
scoring potential interactors are more likely to be relevant, as
supported by comparison to known PDZ domain interac-
tions, analysis of gene function annotation, and comparison
to well-studied examples [10,20,29,40]. This is not surprising,
as similar computational methods with the same goal were
successful in previously published PDZ domain studies
[18,20,40]. Our list of prioritized interactions is a useful
resource for biologists interested in further studying poten-
tial interactions involving PDZ domains. Ideally, this will lead
to discovery of additional PDZ interactions that can be used
to improve performance of computational protein interac-
tion prediction methods.
The PDZ speciﬁcity map is useful for a number of
applications. Our analysis reveals numerous viral proteins
that may interact with PDZ domains to hijack host cellular
networks for pathogen beneﬁt. Based on our data, we were
able to design synthetic viral-like peptides that target a
speciﬁc biological system in human T cells. Analogously,
therapeutics could be designed to alter PDZ-based cell
systems for medical beneﬁt [9], following approaches similar
to those used for the development of peptidomimetics
targeting other peptide-binding modules [46]. Our speciﬁcity
map will prove invaluable for guiding peptidomimetic design,
as it offers starting points for numerous PDZ domain
speciﬁcity classes, provides optimal PDZ-binding peptides
useful for target validation in cellular assays, and helps
identify related domains and potential in vivo interaction
partners that must be considered for cross-reactivity. Further,
the versatility and robustness of the PDZ domain make it
ideal for use in engineering synthetic biological systems [47].
Correct use and interpretation of our speciﬁcity map
requires understanding of its physiological relevance. The
map was constructed using optimal binding ligands detected
by phage display. In the cell, however, natural ligands often
bind suboptimally to enable regulation in signaling systems,
and may have noncanonical binding modes. Multiple cellular
factors must be considered to determine physiologically
relevant binding using our data, including afﬁnity, concen-
tration, localization, and competition between similar PDZ
domains for the same ligands.
Nevertheless, our C-terminal PDZ ligand dataset deﬁnes
the diverse speciﬁcities of the PDZ domain family that have
enabled the evolution of complex cellular architecture and
provides a strong foundation for further work investigating
physiologically relevant interactions. Further, the experimen-
tal and computational methods we describe are readily
applicable to dozens of families of peptide recognition
domains, covering a signiﬁcant fraction of cell signaling
proteins in eukaryotic genomes. We anticipate that deriva-
tion of speciﬁcity maps for all peptide recognition domains
will enable the accurate prediction of physiologically relevant
wiring diagrams directly from sequenced genomes.
Materials and Methods
PDZ domain identiﬁcation. For cloning, the domain boundaries
were deﬁned as the union of all domains found by a combination of
the National Center for Biotechnology Information (NCBI) BLAST
[31], PFAM [32], and SMART [33] with an additional ten amino acids
on each side, as described previously [28]. For computational analysis,
PDZ domain sequences were deﬁned using hmmpfam precomputed
by Ensembl [48] and downloaded from Ensembl 36 (homo_sapien-
s_core_36_35i and caenorhabditis_elegans_core_36_140c) us-
ing the Ensembl Perl API. Other domain resources were used to
manually supplement this list when PDZ domains of interest were not
found in Ensembl. Percent sequence identity was determined using a
multiple sequence alignment of all human and worm PDZ domain
sequences generated using MUSCLE 3.6 [49] with default parameters.
Sequence identity was calculated as: number of matched positions
divided by (aligned sequence length minus gap positions).
PDZ domain cloning and expression. DNA fragments encoding
PDZ domains of interest (Tables S1 and S2) were ampliﬁed from
cDNA using the polymerase chain reaction and were cloned into
vectors designed for the expression and puriﬁcation of PDZ domains
fused to glutathione S-transferase, as described [20,28]. All expression
vectors were veriﬁed by DNA sequencing.
Selection of PDZ domain ligands. C-terminal phage-displayed
peptide libraries (.10
10 unique members) were used to isolate ligands
for PDZ domains using a series of iterative panning steps, as
described [28]. Speciﬁc binding clones were individually tested for
positive interactions with cognate PDZ domains by phage ELISA.
Speciﬁc binding clones derived from sibling phages (identical in DNA
sequence) were only counted once. This resulted in the isolation of
3,100 unique peptides from over 10,000 sequenced peptides for 82
PDZ domains. Data for six domains (ERBB2IP-1, SCRIB-1, SCRIB-2,
SCRIB-3, TJP1–1, and TJP2–2) were from a previous study [20]. For
other natural PDZ domains, a random decapeptide library was used
in binding selections performed at room temperature. For the
analysis of ERBB2IP-1 point mutants, a random heptapeptide library
was used at 4 8C. A ﬁnal manual inspection of all sequences removed a
small number (92) that did not conform to the canonical C-terminal
binding mode or did not agree with the major speciﬁcity proﬁle
(these sequences are available in our online ﬁles at http://baderlab.
org/Data/PDZ).
Speciﬁcity potential. For each PDZ domain, the set of peptide
ligands was used to create a binding proﬁle statistical model as a
PWM. The SP for a given column (position) of a PWM was calculated
as is done for the letter height in a sequence logo [34], except
normalized to range from 0 to 1 instead of 0 to 4.32 (log 20). A SP
value of one means the given PDZ domain is completely speciﬁc for a
single amino acid at that position, and a value of zero means that
there is no preferred amino acid at that position. As no domains
exhibited speciﬁcity at position 9, the SP value for each position was
corrected for bias in the peptide library by subtracting the speciﬁcity
score at position  9 for the entire set of 3,066 unique PDZ domain
ligands (peptides found to bind to the 82 natural PDZ domains in the
speciﬁcity map).
Speciﬁcity map construction. A speciﬁcity map (Figure 2) was
constructed by clustering all 82 natural human and worm PDZ
domain speciﬁcity proﬁles. We used hierarchical agglomerative
clustering with average linkage with a custom speciﬁcity proﬁle
(PWM) distance metric, deﬁned below. Each set of binding peptides
was aligned, anchored by the C terminus, and used to create a
speciﬁcity proﬁle statistical model as a position weight matrix (PWM).
Since the peptide library was constructed using a 32-codon set
deﬁned by the NNK nucleotide ambiguity codes, it is expected that
some amino acids occur more frequently than others. To correct for
this bias, the PWM was normalized by dividing amino acid
frequencies by their expected frequency in the NNK codon set,
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The PDZ Domain Family Specificity Mapfollowing established practice [36]. To consider physicochemical
similarities among amino acids and enable a more biologically
relevant PWM similarity calculation, PWMs were recalculated to use a
reduced amino acid alphabet of ﬁve groups constructed as follows:
STQN (polar), KRH (basic), DE (acidic), FLAMPWIVCY (hydro-
phobic), and G. Distance between PWM pairs a and b, D(a,b), was
then calculated using the following distance metric:
Dða;bÞ¼
1
w
X w
i¼1
1
2
X
L2R
ðai;L   bi;LÞ
2; ð1Þ
where a ¼ PWM A; b ¼ PWM B; w ¼ number of columns in the PWM
(i.e., ten–amino acids peptide length);
P
¼ alphabet used in PWM ¼
the number of rows in the PWM (i.e., ﬁve groups for the reduced
alphabet deﬁned above); and L ¼ a letter from the reduced alphabet.
This distance metric is normalized such that zero represents
perfectly similar PWMs and one represents perfectly dissimilar
PWMs. Similarity is calculated as 1   distance. The clustering results
were visualized in standard fashion (as a tree with branch lengths
corresponding to PWM pair distances). Leaf ordering for graphical
tree display was optimized using the algorithm of Bar-Joseph et al.
[50]. Clustered PWMs were graphically represented using sequence
logos [34] and displayed as leaves on the cluster tree. Summary PWMs
were constructed for all tree nodes as averages of all leaf node PWMs
connected to that node and displayed on each tree node with a size
proportional to their horizontal position in the tree. Software for
creating this tree is available from http://baderlab.org/Software/
LOLA. The tree was manually annotated by an expert (SSS) to deﬁne
speciﬁcity classes.
Erbin mutant heat map construction. Each row of the heat map
depicted in Figure 4 represents one of 91 Erbin mutants, and each
column represents one of seven positions in the mutant speciﬁcity
proﬁle. To quantify the difference between mutant and wild-type
proﬁles, both proﬁles were statistically modeled as PWMs and
compared using the distance metric, D, described above, on a per
PWM position basis (one position per heat map table cell). PWMs
used 20 amino acids, instead of the reduced set described above, to
provide a more ﬁne-grained measure of PWM distance (which
requires that the
P
parameter in Equation 1 be the set of 20 amino
acids). Resulting differences were then normalized across all 91
mutants per position (that is, over an entire column). The linear color
gradient represents the difference of the mutant speciﬁcity proﬁle
compared to wild type, from minimum (blue) to maximum (red)
distance. Signiﬁcant differences are greater than one standard
deviation away from the mean and highlighted in green. The map
was then manually annotated with relevant sequence logos and
structures.
Prioritization of endogenous PDZ domain ligands. The PWM
representing the speciﬁcity proﬁle for each of the 82 mapped PDZ
domains was used to search for C-terminal matches in the RefSeq
human proteome (;33,700 proteins) and viral proteome (;54,600
proteins) sets, downloaded May 21, 2007 [51]. SCRIB viral ligands
were chosen in a more focused, but earlier, search of the RefSeq viral
database from July 15, 2006, containing approximately 48,000 viral
proteins and an additional set of inﬂuenza virus proteomes [13]. One
pseudocount was added to each cell of the PWM to allow a low level
of matching for amino acids that are not seen by phage display, but
nevertheless, may be involved in a natural interaction. Matching
potential ligands not having a hydrophobic C terminus were
removed, since it is known from structural evidence that the PDZ
domain is highly speciﬁc for hydrophobes at this position. A small
number (;10 ligands) were eliminated using this ﬁlter. PWM scores
are calculated as the negative base 10 logarithm of the normalized
probability of the PWM sequence match, such that low, positive
scores represent better PWM matches. To enable comparisons across
PWMs, scores were normalized to the range deﬁned by the maximum
and minimum possible scores that could be produced by the given
PWM. Human proteome PWM score thresholds were calculated
automatically for each PDZ domain by progressively testing increas-
ing score thresholds and choosing a cutoff score when the number of
new hits at a given threshold was higher than the cumulative number
of hits of all previously tested thresholds (not including the last score
tested). Viral PWM score cutoffs were deﬁned to be better than the
best human scoring match to ensure that only viral interactions with
closer PWM matches than any human protein were predicted as viral
PDZ ligands. Viral proteome matches in proteins that contained the
string ‘‘phage’’ in their descriptions were removed, as these viruses
likely target bacteria, not eukaryotic cells.
Additional ligands can be found by choosing a more liberal score
threshold. We chose not to optimize the score threshold to maximize
overlap of predicted interactions to a benchmark, since we could ﬁnd
no suitable benchmark. Available interactions in which the PDZ
domain involved in the interaction was known were too few, and
remaining interactions involved full-length proteins without domain-
level resolution. We did not complete this conservative prioritization
for worm due to the absence of almost any known interactions for
worm PDZ domain containing proteins and poor Gene Ontology
(GO) annotation coverage for predicted ligands.
The overlap statistic was computed based on all protein
interactions involving our mapped PDZ domains in the UniHI
database [52]. Approximately 8% (27) of prioritized interactions are
known, which corresponds to a p-value of 8.6310
 18. The p-value was
computed by calculating the overlap of 1,000 random shufﬂings of
our prioritized interactions with the UniHI benchmark. Our
randomly shufﬂed prioritized interactions overlapped approximately
6.7 interactions in the benchmark on average, with a standard
deviation of approximately 3.4 and with a normal distribution. The
normal distribution was used to calculate the p-value.
Gene Ontology. For predicted endogenous PDZ domain ligands,
GO term enrichments were computed against all available GO
annotation packaged with BiNGO on January 17, 2007, using the
BiNGO Cytoscape plugin [53,54] with HUGO gene identiﬁers, the
hypergeometric statistical test of signiﬁcance, and Benjamini and
Hochberg False Discovery Rate (FDR) correction with a signiﬁcance
level of 0.05.
Software. All computational analyses were performed using
custom Java software built with BioJava 1.4 and JFreeChart. Free,
open source Java software for visualizing and clustering speciﬁcity
proﬁles is available from http://baderlab.org/Software/LOLA and for
searching sequence databases using a speciﬁcity proﬁle to ﬁnd
potential protein interactions via a Cytoscape plugin from http://
baderlab.org/Software/BRAIN.
Data. All peptide sequences are available from http://baderlab.org/
Data/PDZ and have been submitted to the DOMINO and PDZBase
(accession codes cpe_3 to cpe_176) databases.
Afﬁnity assays. Peptides were synthesized with acetylated C
termini. The binding afﬁnities of peptides for PDZ domains were
determined as 50% inhibition concentration (IC50) values using
competition ELISAs, as described [20]. The IC50 value was deﬁned as
the concentration of peptide that blocked 50% of PDZ domain
binding to immobilized peptide.
T cell assays. Naı ¨ve Crtam
 /  CD4 T cells were puriﬁed and
activated with plate-bound anti-CD3 and anti-CD28, as described
[40]. On day 4, T cells were electroporated with 4 lg of pIRES_GFP
or pIRES_GFP/Crtam plasmid DNA by Amaxa Nucleofector (pro-
gram X-01). Synthetic peptides (1.0 lM) were added into the cultures,
and after 6 h, transfected cells were restimulated at 1 3 10
6 cells/ml
with plate-bound antibodies and were ﬁxed 14 h later for Talin
staining. After 42 h, [
3H]-thymidine (1 lCi/well) was added, and the
plates were harvested 8 h later.
Supporting Information
Figure S1. Speciﬁcity Proﬁles for Point Mutants of ERBB2IP-1
Each column heading shows the wild-type sequence at each position,
which is labeled according to a structure-based nomenclature shown
in Figure 4 [36]. Each column shows the speciﬁcity proﬁles for the
point mutants analyzed at that position, and the identity of each
mutation is indicated to the left of each proﬁle. The wild-type proﬁle
as observed at 4 8C is shown for comparison in the box at bottom left.
The speciﬁcity proﬁles were derived from approximately 3,400
binding peptide sequences.
Found at doi:10.1371/journal.pbio.0060239.sg001 (3.85 MB PDF).
Figure S2. PDZ Domain Sequence Identity Accurately Predicts
Binding Speciﬁcity
The relationship between overall PDZ domain sequence identity and
speciﬁcity proﬁle similarity. Each point represents a pair of PDZ
domains from our mapped set. Red circles represent pairs assigned to
the same class, as deﬁned in our speciﬁcity map, and blue squares
represent all other pairs.
Found at doi:10.1371/journal.pbio.0060239.sg002 (267 KB PDF).
Figure S3. Gene Ontology Terms Associated with Endogenous
Prioritized Human PDZ Ligands
Overrepresented terms for the human proteins in Table S5 were
calculated using the BiNGO plugin for Cytoscape and shown as
circles [53,54]. Arrows connect less speciﬁc to more speciﬁc terms, as
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The PDZ Domain Family Specificity Mapdeﬁned in GO. The area of a given node is proportional to the
number of genes annotated in the corresponding GO category in our
set of prioritized ligands. The node color scale is proportional to the
p-value of the overrepresentation of the GO term in the set relative to
the number of genes in the genome. White nodes are not signiﬁcantly
overrepresented, however they are included in order to illustrate the
GO structure within the three different categories.
(A) GO biological process.
(B) GO molecular function.
(C) GO cellular localization.
Found at doi:10.1371/journal.pbio.0060239.sg003 (850 KB PDF).
Figure S4. Gene Ontology Terms Associated with Endogenous
Predicted Ligands for the PDZ Domains of DLG1
Overrepresented GO biological process terms for the proteins in
Table S6 were calculated using the BiNGO plugin for Cytoscape and
shown as circles [53,54]. The analysis was performed as in Figure S3.
Found at doi:10.1371/journal.pbio.0060239.sg004 (270 KB PDF).
Table S1. Summary of Analyzed C. elegans PDZ Domains
The domains are colored as follows: green, puriﬁed and peptide-
phage selections were successful; blue, puriﬁed but peptide-phage
selections were unsuccessful; grey, not cloned or could not be
puriﬁed in a soluble form from Escherichia coli. The listed amino acid
ranges indicate the length of the constructs used in the analysis and
not necessarily the PDZ domain boundaries deﬁned by computa-
tional domain identiﬁcation.
Found at doi:10.1371/journal.pbio.0060239.st001 (43 KB PDF).
Table S2. Summary of Analyzed Human PDZ Domains
The domains are colored as follows: green, puriﬁed and peptide-
phage selections were successful; blue, puriﬁed but peptide-phage
selections were unsuccessful; grey, not cloned or could not be
puriﬁed in a soluble form from E. coli. The listed amino acid ranges
indicate the length of the constructs used in the analysis and not
necessarily the PDZ domain boundaries deﬁned by computational
domain identiﬁcation.
Found at doi:10.1371/journal.pbio.0060239.st002 (47 KB PDF).
Table S3. SP Values for Human and C. elegans PDZ Domains
Values were only determined for 72 domains that had ten or more
selected peptides. C. elegans domains are highlighted in yellow, and
values greater than or equal to 0.2 are highlighted in green.
Found at doi:10.1371/journal.pbio.0060239.st003 (41 KB PDF).
Table S4. PDZ Domain Speciﬁcity Prediction
Speciﬁcity of unmapped domains is predicted to be highly similar
(.0.83 proﬁle similarity) to the mapped domains with greater than
70% sequence identity in the binding site. The species of origin is
shown to the right of each domain.
Found at doi:10.1371/journal.pbio.0060239.st004 (9.07 MB PDF).
Table S5. Prioritized Endogenous and Viral Ligands for Human PDZ
Domains
PDZ domains are listed in alphabetical order and prioritized ligands
are listed in ascending order by interaction score. Lower interaction
scores are better. For each domain, only those viral ligands with
better scores than the best endogenous ligand are shown. Viral or
known endogenous ligands are highlighted in magenta or yellow,
respectively.
Found at doi:10.1371/journal.pbio.0060239.st005 (74 KB PDF).
Table S6. Prioritized Endogenous Ligands for the PDZ Domains of
DLG1
PDZ domains are listed in numerical order, and for each, the 50
ligands with the best prediction score are listed in ascending order by
interaction score. Lower interaction scores are better. Known ligands
reported in PDZBase for DLG1 or the other DLG homologs (DLG2,
 3, and  4) are highlighted in yellow or blue, respectively.
Found at doi:10.1371/journal.pbio.0060239.st006 (41 KB PDF).
Table S7. Known Ligands for the PDZ Domains of DLG1
Known ligands reported in PDZBase are ordered in ascending order
of interaction score for the highest scoring PDZ domain (Table S6).
Lower interaction scores are better. NA denotes ligands that were not
predicted by the scoring algorithm.
Found at doi:10.1371/journal.pbio.0060239.st007 (24 KB PDF).
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